Pediatric Cancer Research, a Culture of Hope
Dear Colleagues, Partners, Patients and Families,
Welcome to the April 2013 edition of the Director's Update. In this issue, I am pleased to highlight our outstanding pediatric cancer research programs, investigators, and clinicians, and in particular, the pediatric team at the Clinical Trials Office.
MCW's pediatric cancer research programs represent some of the strongest science at the institution, with a long history of success and innovation. This knowledge and experience impacts all cancer research efforts at MCW.
We are grateful to the Midwest Athletes Against Childhood Cancer (MACC Fund) and their generous support of pediatric cancer research at MCW. As federal funding for cancer research declines, we are lucky to have such a strong local partner to help us continue childhood cancer research and develop treatments.
Our success in pediatric cancer research is also possible through our partnership with Children’s Hospital of Wisconsin, led by president and CEO Peggy Troy, RN, MSN. One of only 21 designated Children’s Oncology Group (COG) centers, CHW is part of an elite network of national and international cancer trials available nowhere else in the region. The ability to share data and collaborate with the COG network gives us the chance to study and understand more and rarer cancers, and gives patients access to the very newest pediatric cancer treatments.
MCW is fortunate to have a wealth of talent in many areas of pediatric cancer research. We are pleased to welcome Dr. Robert Lane as the new chair of pediatrics at MCW, and I want to thank him for agreeing to serve on the Cancer Center's Internal Scientific Advisory Board (ISAB). Dr. Bruce Camitta continues his 30 years of pioneering work in leukemia, joined by Dr. Michael Kelly and many other clinicians and researchers. Combined with more recent work in other areas of pediatric cancer research, like Dr. Marcio Malagolowkin’s studies in rare liver and kidney tumors, MCW and CHW continue as innovators and leaders to this day.
We reached another key Milestone in 2008 when the pediatric Clinical Trials Office (CTO) became the first of our cancer trials teams to organize as a hub and centralize the specialized knowledge and expertise required for successful cancer studies.
Our team of pediatric cancer researchers and the work of the CTO impacts all cancer research at MCW. This research, and clinical trials in particular, have changed the outlook for many types of childhood cancer.
There are many others who play a significant role in the pediatric cancer research at MCW and CHW. I would like to thank them for their knowledge, dedication and hard work. We are privileged to be at an institution that is committed to understanding and arresting these terrible diseases, and improving the difficult treatments involved.
If you have any questions about pediatric cancer research or cancer clinical trials at MCW, please feel free to contact me, my door is always open.